Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTI-NNRTI: Antiviral Dosing in TB/HIV Co-infection
NCT00523458Phase 4Terminated
- Sponsor
- Stanford University
- Start
- Jul 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nevirapine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by Stanford University. Started Jul 2007; status: terminated.
02
Drugs
nevirapineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00523458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523458.